AOmlin Profile Banner
aurelius omlin Profile
aurelius omlin

@AOmlin

Followers
417
Following
241
Media
4
Statuses
179

Medical Oncologist, specialty Uro-Oncology. Co-Organiser of international Advanced Prostate Cancer Consensus Conferene APCCC https://t.co/a1zZHIG8e6

Joined January 2013
Don't wanna be here? Send us removal request.
@weoncologists
Gil Morgan, MD
6 days
Dear Colleagues at #ESMO25 Our Faculty🚨 @AOmlin and @Silke_Gillessen who are chairs of our partners at @APCCC_Lugano 🇨🇭Discuss trials presented here that will be hot topics in Lugano Ping @neerajaiims @tompowles1 @Ecastromarcos @BourlonMaite @cdanicas @nataliagandur
@OncoAlert
OncoAlert
7 days
Dear #ESMO25 Big News from #APCCC26 🚨APCCC is opening a Call for Abstracts! 👉 https://t.co/m1lKsEhhwS Here are @Silke_Gillessen & @AOmlin to tell you why the discussions here in Berlin will be so relevant for APCCC in Lugano 🇨🇭 @APCCC_Lugano Creating new opportunities for
0
6
8
@urotoday
UroToday.com
6 days
Optimized use of immunotherapy and targeted therapies in #mCRPC. Presentation by @AOmlin. #ESMO25 written coverage by @RKSayyid > https://t.co/eB3NDH4Xt5 @myESMO @neerajaiims
0
4
8
@APCCC_Lugano
Advanced Prostate Cancer Consensus Conference
6 days
apccc.org
@OncoAlert
OncoAlert
6 days
Dear Colleagues at #ESMO25 An honor to present our faculty🚨 @Silke_Gillessen and @AOmlin straight from Berlin who discuss about: The Radioligand Therapy Session on #ProstateCancer VERY hot Topics and some that will spark up conversation in Lugano🇨🇭 for #APCCC26 @APCCC_Lugano
0
10
18
@DrRishabhOnco
Dr Rishabh Jain
9 days
🧬 Cribriform architecture changes the story in localized prostate cancer. 🔥 ProtecT 15-year biopsy re-review shows who really needs treatment vs surveillance. 🎯 n = 712 with available slides (13 % cribriform+) 💊 Arms: ▫️ Active monitoring ▫️ Radical prostatectomy ▫️
2
73
159
@PBlanchardMD
Pierre Blanchard, MD
7 days
Elegant discussion by @Tilki_De reconciling EMBARK & PRESTO #ESMO25: 1. Differences in trial size and 1ry endpoint 2. inclusion criteria close, but pts in EMBARK much higher risk 3. PSMA allowed in PRESTO Important to assess individual risk to select pt for intensification
2
24
55
@TylerSbrt
Tyler Seibert MD PhD
8 months
Perhaps most important point by Jonas: If we want to implement screening to spare men from future metastasis, it is critical to reduce overdiagnosis/overtreatment. I think we need to change the definition of “csPCa” @APCCC_Lugano #APCCCDiagnostics25
@OncoAlert
OncoAlert
8 months
LIVE DAY ONE #APCCCDiagnostics25 in Lugano🇨🇭 Dr. Jonas Hugosson🇸🇪 discussing How do you (best evidenced) screen for #ProstateCancer ? MRI detects the vast majority of high-grade prostate cancers, but it also identifies 50% of ISUP Grade 1 cancers, especially larger ones,
1
4
12
@LoebStacy
Stacy Loeb, MD
8 months
Great talk by @TylerSbrt about the complementarity of MRI and PSMA PET, and the future of imaging is quantitative #APCCCDiagnostics25 @OncoAlert
1
10
40
@nataliagandur
Dra. María Natalia Gandur Quiroga
8 months
🌟 LIVE from #APCCC25! #APCCCDiagnostics25 📢 The PSMA train has left the station… are you on it? 🚆 💡 @DrMHofman delivering brilliant insights on the paradigm shift in prostate cancer imaging! @APCCC_Lugano @OncoAlert 🔍 CT/Bone Scan vs. Next-Gen PSMA PET—how do we adapt
0
12
24
@urotoday
UroToday.com
8 months
When to assess biology with a re-biopsy? Presentation by @mishabeltran @DanaFarber. #APCCCDiagnostics25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/3ePA6s9ARQ #APCCC25 @APCCC_Lugano
0
6
13
@nataliagandur
Dra. María Natalia Gandur Quiroga
8 months
🔥 A FANTASTIC Day 2 at #APCCCDiagnostics25 in Lugano! 🎙️ @Silke_Gillessen 🇨🇭 & @AOmlin 🇨🇭 share their insights on this inaugural edition, highlight key takeaways, unexpected surprises, and already set the stage for #APCCCDiagnostics27! 🚀 Looking ahead to the future of
@OncoAlert
OncoAlert
8 months
A GREAT DAY 2 of #APCCCDiagnostics25 from Lugano @Silke_Gillessen 🇨🇭& @AOmlin 🇨🇭 Give us their take of this inaugural edition of this meeting, unexpected surprises and leave us already looking forward to #APCCCDiagnostics27 @APCCC_Lugano #ProstateCancer 🚨 @OncoAlert
0
3
9
@weoncologists
Gil Morgan, MD
11 months
The @APCCC_Lugano #APCCC24 Webinar on Management of patients with Advanced #ProstateCancer : Cases from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 https://t.co/PSTv7jqCSp ENTIRE WEBINAR HERE in this post @Silke_Gillessen & @AOmlin
@OncoAlert
OncoAlert
11 months
A great Pleasure to Present the first @APCCC_Lugano #APCCC24 Webinar on Management of patients with Advanced #ProstateCancer : Cases from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 https://t.co/iZyneNeXzb ENTIRE WEBINAR HERE in this post The 2024 Advanced Prostate Cancer
0
5
16
@APCCC_Lugano
Advanced Prostate Cancer Consensus Conference
1 year
A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 https://t.co/dyTV0eN9zy The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in
4
115
238
@LoebStacy
Stacy Loeb, MD
1 year
🌍 Just in time for #EarthMonth, check out my new paper “Engaging in Clinical Research & Practice Approaches that Reduce Environmental Impact.” Thx to the team @EurUrolOncol for this opportunity- so many ways we can make a difference! 🌱 Full text link: https://t.co/fb41oaOObv
0
4
18
@piet_ost
Piet Ost
1 year
When Oligometastatix (aka me) and Pelvix (aka @VedangMurthy) share a 3h train ride home from #APCCC24 , new trials are born! Be ready for us #APCCC30! Thanks again @Silke_Gillessen and @AOmlin for having us.
4
9
82
@Prof_IanD
Ian Davis (Bluesky @profiand)
1 year
Sad to be leaving #APCCC24 and beautiful Lugano, but what a fantastic meeting it has been. Plenty to think about, and some practice-changing information. Thank you @Silke_Gillessen @AOmlin @APCCC_Lugano for giving me the joy and privilege of being part of such a great community.
2
3
28
@Silke_Gillessen
silke gillessen
1 year
Agree, one of the best and most comprehensive talks I have ever heard about the topic- and in 10 minutes! Thanks @heatherhcheng !
@neerajaiims
Neeraj Agarwal, MD, FASCO
1 year
#APCCC24 @APCCC_Lugano 👉Excellent talk by @heatherhcheng on who should undergo germ line testing?👉ongoing neoadjuvant trials in germline mutation+ #prostatecancer and take home message👇@OncoAlert @PCF_Science @Silke_Gillessen
0
3
13
@nataliagandur
Dra. María Natalia Gandur Quiroga
1 year
💫🌟 #APCCC24 Day 3️⃣ Highlights 🌟💫 @APCCC_Lugano @OncoAlert @Silke_Gillessen @AOmlin 1. 🧬 Dr. Heather Cheng - Urgency of germline testing in advanced prostate cancer. Detecting mutations to open up personalized treatment options. 🔬 #GeneticsInCancer 2. 🌐 Dr. Ana Aparicio -
1
14
31
@PBlanchardMD
Pierre Blanchard, MD
1 year
And it’s a wrap! It’s been a wonderful and exciting conference. Thanks @Silke_Gillessen @AOmlin and @APCCC_Lugano ! Let’s meet all in 2026 for #APCCC26 And next year for APCCC Diagnostics led by @ProfKHerrmann and @stefanofanti4 #APCCC24
2
7
21
@Ecastromarcos
Elena Castro
1 year
It has been a fantastic @APCCC_Lugano meeting. Already looking forward to APCCC 2026!
1
8
66
@Silke_Gillessen
silke gillessen
1 year
Thanks Yüksel, was wonderful to have you with us!
@DrYukselUrun
Yüksel Ürün
1 year
A heartfelt thank you to Silke, Aurelius, and all the APCCC staff for organizing such an excellent meeting. Your commitment to excellence shone through, making the event not only successful but also memorable. Your hard work and dedication to every detail truly made a
1
4
12